[ad_1] Acadia Pharmaceuticals Inc (NASDAQ: ACAD) reported a Q4 EPS loss of $(0.26), missing the consensus of $(0.24) and sales of $136.49…
Read More »
[ad_1] Acadia Pharmaceuticals Inc (NASDAQ: ACAD) reported a Q4 EPS loss of $(0.26), missing the consensus of $(0.24) and sales of $136.49…
Read More »